Summary
CGS 15943 A (a nonxanthine adenosine antagonist) was studied on the protective efficacy of carbamazepine (60 min prior to the convulsive test), diazepam (60 min), diphenylhydantoin (120 min), phenobarbital (120 min), and valproate (30 min) against maximal electroshock-induced convulsions in mice. Moreover, the influence of the adenosine antagonist on 2-chloroadenosine (1 mg/kg, 20 min prior to the test)- and valproate (250 mg/kg, 30 min)-induced inhibitions of locomotor activity was also studied. CGS 15943 A (1 mg/kg) was given 15 min before both tests and all the drugs were administered i.p.
The adenosine antagonist (1 mg/kg) remained without influence upon the protective activity of all studied antiepileptics, reflected by their respective ED50 values against maximal electroshock. However, both 2-chloroadenosine and valproate-induced inhibitions of locomotor activity were attenuated by CGS 15943 A, which alone did not affect this parameter. However, CGS 15943 A (5 mg/kg) diminished the protection offered by diphenylhydantoin, increasing its ED50 value from 13 to 16 mg/kg.
It may be concluded that the protection provided by common antiepileptic drugs against electroconvulsions seems independent of adenosine-mediated inhibition. In the case of diphenylhydantoin, one may suggest the involvement of purinergic transmission in the final anticonvulsant effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chu N-S (1981) Caffeine- and aminophylline-induced seizures. Epilepsia 22: 85–94
Czuczwar SJ, Turski WA, Ikonomidou C, Turski L (1985) Aminophylline and CGS 8216 reverse the protective action of diazepam against electroconvulsions in mice. Epilepsia 26: 693–696
Czuczwar SJ, Ikonomidou C, Kleinrok Z, Turski L, Turski W (1986) Effect of aminophylline on the protective action of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 27: 204–208
Czuczwar SJ, Janusz W, Szczepanik B, Wamil A, Kleinrok Z (1989) Effect of aminophylline upon the protective activity of common antiepileptic drugs and their plasma levels in mice. Neurosci Res 6: 470–474
Czuczwar SJ, Janusz W, Wamil A, Kleinrok Z (1987 a) Inhibition of aminophylline-induced convulsions in mice by antiepileptic drugs and other agents. Eur J Pharmacol 144: 309–315
Czuczwar SJ, Jäckel R, Löscher W (1987 b) Effects of aminophylline and enprofylline on the protective action of phenobarbital against kindled seizures in rats. Epilepsy Res 1: 234–238
Czuczwar SJ, Kleinrok Z, Turski L, Turski WA (1987 c) Effect of aminophylline and enprofylline upon the protective efficacy of common antiepileptic drugs against electroconvulsions in mice. Epilepsia 28: 383–386
Czuczwar SJ, Turski L, Ikonomidou C, Turski WA, Kleinrok Z (1987 d) Purinergic component in the action of common antiepileptic drugs? In: Wolf P, Dam M, Janz M, Dreifuss FE (eds) Advances in epileptology. Raven Press, New York, pp 511–513
Czuczwar SJ, Gasior M, Janusz W, Szczepanik B, Wlodarczyk D, Kleinrok Z (1990 a) Influence of different methylxanthines upon the anticonvulsant action of common antiepileptic drugs in mice. Epilepsia 31: 318–323
Czuczwar SJ, Szczepanik B, Wamil A, Janusz W, Kleinrok Z (1990 b) Differential effects of agents enhancing purinergic transmission upon the antielectroshock efficacy of carbamazepine, diphenylhydantoin, diazepam, phenobarbital, and valproate in mice. J Neural Transm 81: 153–166
Dragunov M, Goddard GV, Laverty R (1985) Is adenosine an endogenous anticonvulsant? Epilepsia 26: 480–487
Fujiwara Y, Sato M, Otsuki S (1986) Interaction of carbamazepine and other drugs with adenosine (A1 and A2) receptors. Psychopharmacology 90: 332–335
Ghai G, Francis JE, Williams M, Dotson RA, Hopkins MF, Cote DT, Goodman FR, Zimmerman MB (1987) Pharmacological characterization of CGS 15943 A: a novel nonxanthine adenosine antagonist. J Pharmacol Exp Ther 242: 784–790
Hammond J, Clanachan AS (1984) [3H]Nitrobenzylthioinosine binding to guinea pig nucleoside transport system: a pharmacological characterization. J Neurochem 43: 1582–1592
Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96: 99–113
Lohse MJ, Klotz K-N, Jakobs KH, Schwabe U (1985) Barbiturates are selective antagonists at A1 adenosine receptors. J Neurochem 45: 1761–1770
Millichap GJ (1965) Anticonvulsant drugs. In: Root WS, Hofmann FG (eds) Physiological pharmacology. Academic Press, New York London, pp 97–173
Phillis JW (1984) Interactions of the anticonvulsant diphenylhydantoin and carbamazepine with adenosine on cerebral cortical neurons. Epilepsia 25: 765–772
Phillis JW, Wu PH (1982) The effect of various centrally active drugs on adenosine uptake by the central nervous system. Comp Biochem Physiol 72 C: 179–187
Rall TW (1985) Central nervous system stimulants. The methylxanthines. In: Gilman AG, Goodman LS (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 589–602
Schwabe U, Ukena D, Lohse MJ (1985) Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedebergs Arch Pharmacol 330: 212–221
Skerrit JH, Davies LP, Johnston GAR (1982) A purinergic component in the anticonvulsant action of carbamazepine. Eur J Pharmacol 82: 195–197
Skerrit JH, Davies P, Johnston GAR (1983) Interactions of the anticonvulsant carbamazepine with adenosine receptors. 1. Neurochemical studies. Epilepsia 24: 634–642
Ukena D, Schirren CG, Schwabe U (1985) Effects of enprofylline on A1 and A2 adenosine receptors. Eur J Pharmacol 117: 25–33
Weir RL, Padgett W, Daly JW, Anderson SM (1984) Interaction of anticonvulsant drugs with adenosine receptors in the central nervous system. Epilepsia 25: 492–498
Williams M, Francis J, Ghai G, Braunwalder A, Psychoyos S, Stone GA, Cash WD (1987) Biochemical characterization of the triazoloquinazoline, CGS 15943A, a novel, non-xanthine adenosine antagonist. J Pharmacol Exp Ther 241: 415–420
Author information
Authors and Affiliations
Additional information
The results of this study were presented during the Spring Meeting of the German Pharmacological Society held at Mainz (March 13–16, 1990)
Rights and permissions
About this article
Cite this article
Czuczwar, S.J., Janusz, W., Szczepanik, B. et al. Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. J. Neural Transmission 86, 127–134 (1991). https://doi.org/10.1007/BF01250573
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250573